NL-OMON45138尚未招募不适用
ongitudinal analysis of RCC-specific immunity in renal cell carcinoma patients - Analysis of RCC-specific immunity in RCC patients
ederlands Kanker Instituut0 个研究点目标入组 600 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Histologically or cytologically proven renal cell carcinoma
- •Measurable metastatic lesion(s), according to RECIST 1.1 criteria
- •Metastatic lesion(s) of which a histological biopsy can safely be obtained
- •Age above 18 years
- •Performance score: WHO 0, 1 or 2
- •Written informed consent
排除标准
- •see inclusion criteria
研究者
相似试验
已完成
不适用
Immune-related gene signiture profiling in CRC, non-CRC, and lung cancer.JPRN-UMIN000029565ational Cancer Center, Japan651
进行中（未招募）
1 期
Evaluation of immunological response following a revaccination with a non-conjugated pneumococcal vaccine boosted or not by a conjugated pneumococcal vaccine in splenectomised patients (SPLENEVAC-2)Asplenic patients at risk for invasive pneumococcal diseasesMedDRA version: 20.0Level: PTClassification code 10041642Term: SplenectomySystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2018-003068-29-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)56
进行中（未招募）
不适用
A Clinical trial to analysis of immune profile following neoadjuvant chemotherapy in colorectal liver metastases patientsNeoplasmsKCT0003474Asan Medical Center20
已完成
不适用
Characterization of the immune response in patients with urothelial cell carcinoma of the bladder and during the BCG immunotherapy of bladder cancerC67Malignant neoplasm of bladderDRKS00003700Chirurgische Universitätsklinik, Abteilung für Urologie410
已完成
不适用
Study of immune parameters that may differ between HC and patients with MS : an explorative studyMS1000381610007951Multiple SclerosisNL-OMON37483School for Mental Health and Neuroscience100